The notable prevalence of Farmapram, a formulation containing 2mg alprazolam, has triggered significant discussion regarding its availability and the associated dangers. While designed for the control of anxiety disorders and panic episodes, concerns are emerging about its unregulated procurement, particularly through unverified sellers. This scena